» Articles » PMID: 24646301

ShatterProof: Operational Detection and Quantification of Chromothripsis

Overview
Publisher Biomed Central
Specialty Biology
Date 2014 Mar 21
PMID 24646301
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chromothripsis, a newly discovered type of complex genomic rearrangement, has been implicated in the evolution of several types of cancers. To date, it has been described in bone cancer, SHH-medulloblastoma and acute myeloid leukemia, amongst others, however there are still no formal or automated methods for detecting or annotating it in high throughput sequencing data. As such, findings of chromothripsis are difficult to compare and many cases likely escape detection altogether.

Results: We introduce ShatterProof, a software tool for detecting and quantifying chromothriptic events. ShatterProof takes structural variation calls (translocations, copy-number variations, short insertions and loss of heterozygosity) produced by any algorithm and using an operational definition of chromothripsis performs robust statistical tests to accurately predict the presence and location of chromothriptic events. Validation of our tool was conducted using clinical data sets including matched normal, prostate cancer samples in addition to the colorectal cancer and SCLC data sets used in the original description of chromothripsis.

Conclusions: ShatterProof is computationally efficient, having low memory requirements and near linear computation time. This allows it to become a standard component of sequencing analysis pipelines, enabling researchers to routinely and accurately assess samples for chromothripsis. Source code and documentation can be found at http://search.cpan.org/~sgovind/Shatterproof.

Citing Articles

The Landscape of Prostate Tumour Methylation.

Arbet J, Yamaguchi T, Shiah Y, Hugh-White R, Wiggins A, Oh J bioRxiv. 2025; .

PMID: 39990314 PMC: 11844408. DOI: 10.1101/2025.02.07.637178.


Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets.

Prouteau A, Mottier S, Primot A, Cadieu E, Bachelot L, Botherel N Cancers (Basel). 2022; 14(2).

PMID: 35053440 PMC: 8774001. DOI: 10.3390/cancers14020276.


Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.

Hoogstrate Y, Komor M, Bottcher R, van Riet J, van de Werken H, van Lieshout S Gigascience. 2021; 10(12).

PMID: 34891161 PMC: 8673554. DOI: 10.1093/gigascience/giab080.


Computational analysis of cancer genome sequencing data.

Cortes-Ciriano I, Gulhan D, Lee J, Melloni G, Park P Nat Rev Genet. 2021; 23(5):298-314.

PMID: 34880424 DOI: 10.1038/s41576-021-00431-y.


svpluscnv: analysis and visualization of complex structural variation data.

Lopez G, Egolf L, Giorgi F, Diskin S, Margolin A Bioinformatics. 2020; 37(13):1912-1914.

PMID: 33051644 PMC: 8487630. DOI: 10.1093/bioinformatics/btaa878.


References
1.
Kim T, Xi R, Luquette L, Park R, Johnson M, Park P . Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes. Genome Res. 2012; 23(2):217-27. PMC: 3561863. DOI: 10.1101/gr.140301.112. View

2.
Kloosterman W, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat J . Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer. Genome Biol. 2011; 12(10):R103. PMC: 3333773. DOI: 10.1186/gb-2011-12-10-r103. View

3.
Boeva V, Zinovyev A, Bleakley K, Vert J, Janoueix-Lerosey I, Delattre O . Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization. Bioinformatics. 2010; 27(2):268-9. PMC: 3018818. DOI: 10.1093/bioinformatics/btq635. View

4.
Stephens P, Greenman C, Fu B, Yang F, Bignell G, Mudie L . Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011; 144(1):27-40. PMC: 3065307. DOI: 10.1016/j.cell.2010.11.055. View

5.
Molenaar J, Koster J, Zwijnenburg D, van Sluis P, Valentijn L, van der Ploeg I . Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature. 2012; 483(7391):589-93. DOI: 10.1038/nature10910. View